PubRank

Bette Korber

Author PubWeight™ 128.86‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Diversity considerations in HIV-1 vaccine selection. Science 2002 9.60
2 Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA. Nature 2004 9.53
3 Comprehensive cross-clade neutralization analysis of a panel of anti-human immunodeficiency virus type 1 monoclonal antibodies. J Virol 2004 8.99
4 Structure of a V3-containing HIV-1 gp120 core. Science 2005 7.69
5 Public health. A sound rationale needed for phase III HIV-1 vaccine trials. Science 2004 5.31
6 Founder effects in the assessment of HIV polymorphisms and HLA allele associations. Science 2007 4.60
7 Advantage of rare HLA supertype in HIV disease progression. Nat Med 2003 4.08
8 Tracking global patterns of N-linked glycosylation site variation in highly variable viral glycoproteins: HIV, SIV, and HCV envelopes and influenza hemagglutinin. Glycobiology 2004 3.98
9 Selection for human immunodeficiency virus type 1 envelope glycosylation variants with shorter V1-V2 loop sequences occurs during transmission of certain genetic subtypes and may impact viral RNA levels. J Virol 2005 3.69
10 Transmission and accumulation of CTL escape variants drive negative associations between HIV polymorphisms and HLA. J Exp Med 2005 3.68
11 Mosaic HIV-1 vaccines expand the breadth and depth of cellular immune responses in rhesus monkeys. Nat Med 2010 3.44
12 Quantitative deep sequencing reveals dynamic HIV-1 escape and large population shifts during CCR5 antagonist therapy in vivo. PLoS One 2009 3.40
13 Phenotypic properties of transmitted founder HIV-1. Proc Natl Acad Sci U S A 2013 2.75
14 Design and pre-clinical evaluation of a universal HIV-1 vaccine. PLoS One 2007 2.61
15 Enhanced detection of human immunodeficiency virus type 1-specific T-cell responses to highly variable regions by using peptides based on autologous virus sequences. J Virol 2003 2.53
16 A jumping profile Hidden Markov Model and applications to recombination sites in HIV and HCV genomes. BMC Bioinformatics 2006 2.25
17 HIV sequence databases. AIDS Rev 2003 2.20
18 HIV evolution in early infection: selection pressures, patterns of insertion and deletion, and the impact of APOBEC. PLoS Pathog 2009 2.15
19 Genetic and functional analysis of full-length human immunodeficiency virus type 1 env genes derived from brain and blood of patients with AIDS. J Virol 2003 2.07
20 HIV-1 Nef is preferentially recognized by CD8 T cells in primary HIV-1 infection despite a relatively high degree of genetic diversity. AIDS 2004 1.89
21 HLA-B63 presents HLA-B57/B58-restricted cytotoxic T-lymphocyte epitopes and is associated with low human immunodeficiency virus load. J Virol 2005 1.76
22 The role of recombination in the emergence of a complex and dynamic HIV epidemic. Retrovirology 2010 1.69
23 Analysis of V2 antibody responses induced in vaccinees in the ALVAC/AIDSVAX HIV-1 vaccine efficacy trial. PLoS One 2013 1.65
24 HIV-1 vaccine development after STEP. Annu Rev Med 2010 1.64
25 jpHMM: improving the reliability of recombination prediction in HIV-1. Nucleic Acids Res 2009 1.61
26 Role of maternal autologous neutralizing antibody in selective perinatal transmission of human immunodeficiency virus type 1 escape variants. J Virol 2006 1.59
27 jpHMM at GOBICS: a web server to detect genomic recombinations in HIV-1. Nucleic Acids Res 2006 1.58
28 Recurrent signature patterns in HIV-1 B clade envelope glycoproteins associated with either early or chronic infections. PLoS Pathog 2011 1.57
29 Expanded breadth of the T-cell response to mosaic human immunodeficiency virus type 1 envelope DNA vaccination. J Virol 2008 1.51
30 Genetic signatures in the envelope glycoproteins of HIV-1 that associate with broadly neutralizing antibodies. PLoS Comput Biol 2010 1.51
31 Relationship between functional profile of HIV-1 specific CD8 T cells and epitope variability with the selection of escape mutants in acute HIV-1 infection. PLoS Pathog 2011 1.42
32 Epitope escape mutation and decay of human immunodeficiency virus type 1-specific CTL responses. J Immunol 2003 1.36
33 Clade-specific differences between human immunodeficiency virus type 1 clades B and C: diversity and correlations in C3-V4 regions of gp120. J Virol 2006 1.30
34 Web-based design and evaluation of T-cell vaccine candidates. Bioinformatics 2008 1.30
35 Host genetic profiles predict virological and immunological control of HIV-1 infection in adolescents. AIDS 2002 1.24
36 Antigenicity and immunogenicity of transmitted/founder, consensus, and chronic envelope glycoproteins of human immunodeficiency virus type 1. J Virol 2013 1.24
37 Los alamos hepatitis C immunology database. Appl Bioinformatics 2005 1.23
38 Evolution of hepatitis C viral quasispecies after liver transplantation. Gastroenterology 2002 1.18
39 Coping with viral diversity in HIV vaccine design: a response to Nickle et al. PLoS Comput Biol 2008 1.17
40 Mycobacterium tuberculosis--heterogeneity revealed through whole genome sequencing. Tuberculosis (Edinb) 2012 1.17
41 Cross-reactive CD8+ T cell epitopes identified in US adolescent minorities. J Acquir Immune Defic Syndr 2003 1.10
42 Full-length HIV-1 immunogens induce greater magnitude and comparable breadth of T lymphocyte responses to conserved HIV-1 regions compared with conserved-region-only HIV-1 immunogens in rhesus monkeys. J Virol 2012 1.10
43 Genotype 1 and global hepatitis C T-cell vaccines designed to optimize coverage of genetic diversity. J Gen Virol 2010 1.05
44 Epitope-specific CD8+ T lymphocytes cross-recognize mutant simian immunodeficiency virus (SIV) sequences but fail to contain very early evolution and eventual fixation of epitope escape mutations during SIV infection. J Virol 2011 1.05
45 A multiple-alignment based primer design algorithm for genetically highly variable DNA targets. BMC Bioinformatics 2013 0.94
46 A computational framework for the analysis of peptide microarray antibody binding data with application to HIV vaccine profiling. J Immunol Methods 2013 0.93
47 Fitness costs of rifampicin resistance in Mycobacterium tuberculosis are amplified under conditions of nutrient starvation and compensated by mutation in the β' subunit of RNA polymerase. Mol Microbiol 2014 0.93
48 Designing and testing broadly-protective filoviral vaccines optimized for cytotoxic T-lymphocyte epitope coverage. PLoS One 2012 0.92
49 The evolutionary rate dynamically tracks changes in HIV-1 epidemics: application of a simple method for optimizing the evolutionary rate in phylogenetic trees with longitudinal data. Epidemics 2009 0.89
50 A mechanistic understanding of allosteric immune escape pathways in the HIV-1 envelope glycoprotein. PLoS Comput Biol 2013 0.88
51 Hepatitis C genotype 1 mosaic vaccines are immunogenic in mice and induce stronger T-cell responses than natural strains. Clin Vaccine Immunol 2012 0.84
52 Viral genome analysis and knowledge management. Methods Mol Biol 2013 0.81
53 HIV classification using the coalescent theory. Bioinformatics 2010 0.81
54 T cell responses in HIV type 1-infected adolescent minorities share similar epitope specificities with whites despite significant differences in HLA class I alleles. AIDS Res Hum Retroviruses 2003 0.81
55 Mother-to-child transmission in the United States of subtypes D and A/G human immunodeficiency virus type 1. AIDS Res Hum Retroviruses 2002 0.80
56 The spread of HIV in Africa. J Neurovirol 2005 0.80
57 Capturing viral diversity for in-vitro test reagents and HIV vaccine immunogen design. Curr Opin HIV AIDS 2007 0.78
58 Building on the past to define an efficient path to an HIV vaccine. Expert Rev Vaccines 2011 0.77
59 Research on infectious disease dynamics. Introduction. Epidemics 2009 0.75
60 A plea for justice for jailed medical workers. Science 2006 0.75
61 Correction: Features of Recently Transmitted HIV-1 Clade C Viruses that Impact Antibody Recognition: Implications for Active and Passive Immunization. PLoS Pathog 2017 0.75